General Information of the Compound
| Compound ID |
CP0409321
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-{4-[(5-Bromo-pyridin-2-yl)-(3,4-dichloro-benzyl)-amino]-butyl}-3-[2-(1H-imidazol-4-yl)-ethyl]-thiourea
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H25BrCl2N6S
|
||||||||||||||||||
| Molecular Weight |
556.361
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(CN(CCCCNC(=S)NCCc2cnc[nH]2)c2ccc(Br)cn2)cc1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H25BrCl2N6S/c23-17-4-6-21(29-12-17)31(14-16-3-5-19(24)20(25)11-16)10-2-1-8-27-22(32)28-9-7-18-13-26-15-30-18/h3-6,11-13,15H,1-2,7-10,14H2,(H,26,30)(H2,27,28,32)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JVUDMRCWRBXJRH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01505, Somatostatin receptor type 2
Protein ID: PT01398, Somatostatin receptor type 4